Synlett 2007(14): 2247-2251  
DOI: 10.1055/s-2007-985567
LETTER
© Georg Thieme Verlag Stuttgart · New York

Monooxychlorophosphine as a Novel and Efficient Ligand for Palladium-Catalyzed Suzuki-Miyaura Cross-Coupling of Aryl Chlorides

Wenpeng Mai, Guanghua Lv, Lianxun Gao*
State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Graduate School of Chinese Academy of Sciences, Changchun 130022, P. R. of China
Fax: +86(431)85685653; e-Mail: lxgao@ciac.jl.cn;
Further Information

Publication History

Received 16 May 2007
Publication Date:
13 August 2007 (online)

Abstract

A new sterically hindered monooxychlorophosphine was synthesized and the complex generated in situ from its reaction with Pd2(dba)3 promoted the Suzuki-Miyaura reactions of arylboronic acids with aryl chlorides in good yields.

14

Synthesis of (2,6- t -Bu 2 -4-MeC 6 H 2 O)P(Cl) t -Bu (1): To a flame-dried two-necked flask equipped with an addition funnel were added 2 (1.6 g, 5 mmol) and anhyd Et2O (50 mL) at 0 °C. t-BuMgCl [7.4 mL (1.7 M/L in THF solution), 12.5 mmol] was transferred into an addition funnel and was added dropwise to the stirred solution within 0.5 h. The ice bath was removed and the stirring was continued at r.t. for 20 h and then the mixture was refluxed for 2 h. The solvent was removed under reduced pressure and the residual mixture was extracted with Et2O, washed with aq NaHCO3 (3 × 30 mL) and dried over Na2SO4. The solution was filtered and Et2O was removed and then the residue was recrystallized from absolute ethanol to give 1 as a white solid (83%). 1H NMR (600 MHz, CDCl3): δ = 1.32 (d, J = 12 Hz, 9 H), 1.43 (s, 18 H), 2.27 (s, 3 H), 7.03 (s, 2 H). 31P NMR (242.9 MHz, CDCl3): δ = 217.2 (s). Anal. Calcd for C19H32OPCl: C, 66.55; H, 9.41. Found: C, 66.31; H, 8.72. GC-MS: m/z = 342 [M+].

15

General Procedure for the Suzuki Reaction: A mixture of aryl chlorides 5a-j (1.5 mmol), arylboronic acid 6a-c (1.7 mmol), Pd2(dba)3 (0.0075 mmol), 1 (0.015 mmol), t-BuOK (3 mmol), and THF (5 mL) was added to a flask and stirred at 65 °C under N2 for the desired time until complete consumption of the starting substrates was observed (as judged by TLC). The solvent was removed under reduced pressure, and the residue was purified by flash column chromatography (PE-EtOAc) to afford the desired coupled products.
Compound 7:4a 1H NMR (400 MHz, CDCl3): δ = 7.61 (d, J = 8.0 Hz, 4 H), 7.44 (t, J = 7.2 Hz, 4 H), 7.34 (tt, J = 7.2 Hz, J′ = 1.2 Hz, 2 H). 13C NMR (150 MHz, CDCl3): δ = 141.2, 128.7, 127.2, 127.1.
Compound 8:9b 1H NMR (600 MHz, CDCl3): δ = 7.39 (t, J = 7.2 Hz, 2 H), 7.32 (t, J = 7.2 Hz, 3 H), 7.22-7.25 (m, 4 H), 2.26 (s, 3 H). 13C NMR (150 MHz, CDCl3): δ = 141.9, 135.2, 130.2, 129.7, 129.1, 128.0, 127.2, 126.7, 125.7, 20.4.
Compound 9:9b 1H NMR (600 MHz, CDCl3): δ = 7.58 (d, J = 7.2 Hz, 2 H), 7.38-7.44 (m, 4 H), 7.34 (t, J = 7.2 Hz, 2 H), 7.17 (d, J = 7.8 Hz, 1 H), 2.42 (s, 3 H). 13C NMR (150 MHz, CDCl3): δ = 141.3, 141.2, 138.2, 128.6, 127.9, 127.1, 124.2, 21.5.
Compound 10:16a 1H NMR (400 MHz, CDCl3): δ = 7.48 (d, J = 8.0 Hz, 4 H), 7.24 (d, J = 8.0 Hz, 4 H), 2.39 (s, 6 H). 13C NMR (150 MHz, CDCl3): δ = 138.2, 136.6, 129.4, 126.8, 21.1.
Compound 11:16b 1H NMR (300 MHz, CDCl3): δ = 8.07 (d, J = 6.6 Hz, 2 H), 7.72 (d, J = 6.6 Hz, 2 H), 7.58 (d, J = 6.0 Hz, 2 H), 7.33 (d, J = 9.0 Hz, 2 H), 2.67 (s, 3 H), 2.45 (s, 3 H). 13C NMR (150 MHz, CDCl3): δ = 197.7, 145.7, 138.2, 137.0, 135.6, 129.6, 128.9, 127.1, 126.9, 26.6, 21.1.
Compound 12:16c 1H NMR (600 MHz, CDCl3): δ = 7.71 (dd, J = 8.4 Hz, J′ = 16.2 Hz, 4 H), 7.5 (d, J = 8.4 Hz, 2 H), 7.29 (d, J = 8.4 Hz, 2 H), 2.41 (s, 3 H). 13C NMR (150 MHz, CDCl3): δ = 145.6, 138.7, 136.3, 132.5, 129.8, 127.4, 127.0, 119.0, 110.5, 21.1.
Compound 13:16d 1H NMR (400 MHz, CDCl3): δ = 8.84 (d, J = 2.0 Hz, 1 H), 8.57 (d, J = 3.6 Hz, 1 H), 7.87 (dt, J = 8.0 Hz, J′ = 2.0 Hz, 1 H), 7.49 (d, J = 8.0 Hz, 2 H), 7.37 (dd, J = 4.8 Hz, J′ = 3.2 Hz, 1 H), 7.30 (d, J = 8.0 Hz, 2 H), 2.41 (s, 3 H). 13C NMR (150 MHz, CDCl3): δ = 148.1, 148.0, 138.0, 136.6, 134.8, 134.2, 129.8, 126.9, 123.5, 21.1.
Compound 14:16b 1H NMR (400 MHz, CDCl3): δ = 10.1 (s, 1 H), 7.97 (d, J = 8.4 Hz, 2 H), 7.77 (d, J = 8.4 Hz, 2 H), 7.65 (d, J = 7.2 Hz, 2 H), 7.50 (t, J = 7.2 Hz, 2 H), 7.40-7.43 (m, 1 H). 13C NMR (150 MHz, CDCl3): δ = 191.9, 147.1, 139.7, 135.1, 130.2, 129.0, 128.4, 127.6, 127.3.
Compound 15:4a,9b 1H NMR (400 MHz, CDCl3): δ = 7.54 (t, J = 8.0 Hz, 4 H), 7.41 (t, J = 7.6 Hz, 2 H), 7.30 (t, J = 7.2 Hz, 1 H), 6.99 (dt, J = 8.8 Hz, J′ = 2.0 Hz, 2 H), 3.85 (s, 3 H). 13C NMR (150 MHz, CDCl3): δ = 159.1, 140.8, 133.8, 128.7, 128.1, 126.7, 126.6, 114.2, 55.3.
Compound 16:16e 1H NMR (300 MHz, CDCl3): δ = 7.72 (t, J = 7.2 Hz, 8 H), 7.52 (t, J = 7.2 Hz, 4 H), 7.47 (t, J = 7.2 Hz, 2 H). 13C NMR (150 MHz, CDCl3): δ = 140.7, 140.1, 128.8, 127.5, 127.3, 127.0.
Compound 17:6e 1H NMR (400 MHz, CDCl3): δ = 8.05 (d, J = 8.4 Hz, 2 H), 7.70 (d, J = 8.4 Hz, 2 H), 7.64 (d, J = 7.2 Hz, 2 H), 7.48 (t, J = 7.2 Hz, 2 H), 7.40 (t, J = 7.2 Hz, 1 H), 2.64 (s, 3 H). 13C NMR (150 MHz, CDCl3): δ = 197.7, 145.8, 139.9, 135.8, 128.94, 128.9, 128.2, 127.26, 127.21, 26.7.
Compound 18:7f,9b 1H NMR (400 MHz, CDCl3): δ = 8.86 (d, J = 0.8 Hz, 1 H), 8.60 (d, J = 4.8 Hz, 1 H), 7.88 (dt, J = 8.0 Hz, J′ = 2.0 Hz, 1 H), 7.59 (d, J = 7.2 Hz, 2 H), 7.48 (t, J = 7.2 Hz, 2 H), 7.42 (d, J = 7.2 Hz, 1 H), 7.34-7.36 (m, 1 H). 13C NMR (150 MHz, CDCl3): δ = 148.4, 148.22, 137.7, 136.6, 134.3, 129.0, 128.0, 127.0, 123.5.
Compound 19:16f 1H NMR (400 MHz, CDCl3): δ = 8.01 (d, J = 8.0 Hz, 2 H), 7.64 (d, J = 8.0 Hz, 2 H), 7.32-7.39 (m, 2 H), 7.00-7.07 (m, 2 H), 3.85 (s, 3 H), 2.63 (s, 3 H). 13C NMR (150 MHz, CDCl3): δ = 197.8, 156.4, 143.6, 135.5, 130.7, 129.7, 129.4, 128.0, 120.9, 111.3, 55.5, 26.6.